A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Charité Research Organisation GmbH, Berlin, Germany
Contact: Study coordinator (Boehringer Ingelheim) · deutschland@bitrialsupport.com · 08007234742

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Glendale, United States · Baltimore, United States

First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants

Healthy Participants

Abroad (travel likely)RecruitingPHASE1

Lincoln, United States

A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

Healthy Volunteers · Chronic Kidney Disease

Abroad (travel likely)RecruitingPHASE1, PHASE2

Herston, Australia · Morayfield, Australia

HMOs on Infant Gut Microbiota Modulation and Development of the Immune System in Healthy Infants

Healthy Infants

Abroad (travel likely)Recruiting

Aarhus, Denmark · Aarhus, Denmark